WallStreetZenWallStreetZen

NASDAQ: BCRX
Biocryst Pharmaceuticals Inc Stock Ownership - Who owns Biocryst Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Biocryst Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Amy E. McKeeDirector2025-08-29676$8.31
$5.62kBuy
Vincent MilanoDirector2025-08-29676$8.31
$5.62kBuy
Steven FrankDirector2025-08-291,353$8.31
$11.24kBuy
Theresa HeggieDirector2025-08-1340,000$5.41
$216.40kBuy
Theresa HeggieDirector2025-08-1370,000$8.51
$595.84kSell
Theresa HeggieDirector2025-08-1330,000$2.91
$87.30kBuy
Steven FrankDirector2025-05-30333$10.75
$3.58kBuy
Vincent MilanoDirector2025-05-30523$10.75
$5.62kBuy
Helen M. ThackrayChief RD Officer2025-03-317,525$7.50
$56.44kSell
Vincent MilanoDirector2025-02-28653$8.61
$5.62kBuy

1 of 3

BCRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BCRX insiders and whales buy or sell their stock.

BCRX Shareholders

What type of owners hold Biocryst Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP10.26%21,543,334$170.41MInsider
Blackrock Inc10.21%21,425,849$169.48MInstitution
Vanguard Group Inc9.79%20,544,248$162.51MInstitution
State Street Corp4.05%8,505,392$67.28MInstitution
Kynam Capital Management LP4.03%8,463,742$66.95MInstitution
Alkeon Capital Management LLC2.72%5,714,021$45.20MInstitution
Ubs Group Ag2.67%5,614,651$44.41MInstitution
Morgan Stanley2.54%5,329,679$42.16MInstitution
Geode Capital Management LLC2.41%5,054,610$39.98MInstitution
Deerfield Management Company LP2.24%4,692,000$37.11MInstitution

1 of 3

BCRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BCRX84.08%15.92%Net SellingNet Buying
AUPH44.23%12.63%Net BuyingNet Buying
VCEL91.49%8.51%Net SellingNet Buying
CLDX85.11%14.89%Net BuyingNet Selling
SRPT73.73%26.27%Net SellingNet Selling
View Top Biotech Stocks

Biocryst Pharmaceuticals Stock Ownership FAQ

Who owns Biocryst Pharmaceuticals?

Biocryst Pharmaceuticals (NASDAQ: BCRX) is owned by 93.93% institutional shareholders, 17.78% Biocryst Pharmaceuticals insiders, and 0.00% retail investors. Baker Bros Advisors LP is the largest individual Biocryst Pharmaceuticals shareholder, owning 21.54M shares representing 10.26% of the company. Baker Bros Advisors LP's Biocryst Pharmaceuticals shares are currently valued at $170.41M.

If you're new to stock investing, here's how to buy Biocryst Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.